They played a trick on shareholders by presenting a better offer (about $0.8
Per share) first . After getting enough number of voted shares, they amended the original offer. That is the trick or so called tactics.
Just my opinion.
I am surprised nobody complained about this to ASIC
tamiflu weakness is glaxo's strength , page-10
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)